BioFuel Enters Into Bridge Loan Agreement

BIOFUEL ENERGY CORP. (Nasdaq: BIOF), an ethanol production company, today announced that it has entered into a six-month bridge loan agreement with Greenlight Capital, Inc. and certain of its affiliates (collectively, "Greenlight") and an affiliate of Third Point LLC ("Third Point"). The proceeds from the bridge loan were used to repay in full its working capital loans under its senior debt facility. In addition, the Company has entered into an agreement with Greenlight and Third Point pursuant to which it has agreed to conduct a rights offering in which all holders of its Common Stock and Class B Common Stock will be granted the right to purchase convertible preferred stock of the Company, with the goal of generating sufficient proceeds to repay the bridge loan and BioFuel Energy, LLC's subordinated debt and to make certain other payments. These transactions were recommended to the Company's Board of Directors by a Special Committee comprised of independent directors. The Special Committee was advised by Piper Jaffray & Co.

Delta BC– April 27 2010  - www.RenewableEnergyStocks.com, a leading investor news and research portal for the renewable energy sector within www.Investorideas.com, reports Codexis, Inc. (Nasdaq: CDXS) commenced trading on The NASDAQ Stock Market April 22.. Codexis, Inc., trading under the ticker symbol (CDXS), raised $78 million at $13 per share.

Codexis, Inc. (Nasdaq: CDXS) is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and have the potential to make new industrial processes possible at commercial scale. Codexis has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration. The company is also using its technology platform to pursue biocatalyst-enabled solutions in other bioindustrial markets, including carbon management, water treatment and chemicals.

BioFuel Reports Fourth Quarter and Year End 2009 Results

BIOFUEL ENERGY CORP. (Nasdaq: BIOF), an ethanol production company, today announced its fourth quarter and year end 2009 results. Net income attributable to common shareholders was $6.8 million, or $.21 per diluted share, for the quarter ended December 31, 2009. For the year ended December 31, 2009, the net loss attributable to common shareholders was $13.6 million, or $.57 per share. For the quarter ended December 31, 2009, revenues totaled $120.4 million, which were comprised of $105.8 million from sales of ethanol and $14.6 million from sales of distillers grain. For the year ended December 31, 2009, revenues totaled $415.5 million, comprised of $353.7 million from sales of ethanol and $61.8 million from sales of distillers grain.

Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy

Medicago Inc. (TSX-V: MDG.V), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate. Medicago will work with ECBC to investigate the affordable production of industrial enzymes in the field of biofuels. This new project builds on Medicago's proprietary plant-based manufacturing platform and its potential for applications beyond the biological drug market.